Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory D Curfman

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
The New England Journal of Medicine|September 5, 2008
The FDA and tobacco regulationGregory D Curfman, Stephen Morrissey, Jeffrey M Drazen
The New England Journal of Medicine|June 7, 2007
Rosiglitazone--continued uncertainty about safetyJeffrey M Drazen, Stephen Morrissey, Gregory D Curfman
The New England Journal of Medicine|November 3, 2006
Retraction: Sudbø J et al. DNA content as a prognostic marker in patients with oral leukoplakia. N Engl J Med 2001;344:1270-8 and Sudbø J et al. The influence of resection and aneuploidy on mortality in oral leukoplakia. N Engl J Med 2004;350:1405-13Gregory D Curfman, Stephen Morrissey, Jeffrey M Drazen
The New England Journal of Medicine|June 24, 2009
Tobacco, public health, and the FDAGregory D Curfman, Stephen Morrissey, Jeffrey M Drazen
The New England Journal of Medicine|October 29, 2010
Products at riskGregory D Curfman, Stephen Morrissey, Jeffrey M Drazen
The New England Journal of Medicine|January 4, 2013
Affirmative action in the balanceGregory D Curfman, Stephen Morrissey, Jeffrey M Drazen
The New England Journal of Medicine|September 8, 2010
Sibutramine--another flawed diet pillGregory D Curfman, Stephen Morrissey, Jeffrey M Drazen
The New England Journal of Medicine|December 13, 2005
Expression of concern: Bombardier et al., "Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis," N Engl J Med 2000;343:1520-8Gregory D Curfman, Stephen Morrissey, Jeffrey M Drazen
JAMA Internal Medicine|November 14, 2017
The Supreme Court Ruling in Sandoz v Amgen: A Victory for Follow-on BiologicsAmeet Sarpatwari, Abbe R Gluck, Gregory D Curfman
The New England Journal of Medicine|October 5, 2007
Open clinical trialsJeffrey M Drazen, Stephen Morrissey, Gregory D Curfman
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
The New England Journal of Medicine|September 5, 2008
The FDA and tobacco regulationGregory D Curfman, Stephen Morrissey, Jeffrey M Drazen
The New England Journal of Medicine|June 7, 2007
Rosiglitazone--continued uncertainty about safetyJeffrey M Drazen, Stephen Morrissey, Gregory D Curfman
The New England Journal of Medicine|November 3, 2006
Retraction: Sudbø J et al. DNA content as a prognostic marker in patients with oral leukoplakia. N Engl J Med 2001;344:1270-8 and Sudbø J et al. The influence of resection and aneuploidy on mortality in oral leukoplakia. N Engl J Med 2004;350:1405-13Gregory D Curfman, Stephen Morrissey, Jeffrey M Drazen
The New England Journal of Medicine|June 24, 2009
Tobacco, public health, and the FDAGregory D Curfman, Stephen Morrissey, Jeffrey M Drazen
The New England Journal of Medicine|October 29, 2010
Products at riskGregory D Curfman, Stephen Morrissey, Jeffrey M Drazen
The New England Journal of Medicine|January 4, 2013
Affirmative action in the balanceGregory D Curfman, Stephen Morrissey, Jeffrey M Drazen
The New England Journal of Medicine|September 8, 2010
Sibutramine--another flawed diet pillGregory D Curfman, Stephen Morrissey, Jeffrey M Drazen
The New England Journal of Medicine|December 13, 2005
Expression of concern: Bombardier et al., "Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis," N Engl J Med 2000;343:1520-8Gregory D Curfman, Stephen Morrissey, Jeffrey M Drazen
JAMA Internal Medicine|November 14, 2017
The Supreme Court Ruling in Sandoz v Amgen: A Victory for Follow-on BiologicsAmeet Sarpatwari, Abbe R Gluck, Gregory D Curfman
The New England Journal of Medicine|October 5, 2007
Open clinical trialsJeffrey M Drazen, Stephen Morrissey, Gregory D Curfman
Pageof 7